Effect of sphingomyelinase treatment on ligand binding activity of human serotonin1A receptors

Jafurullaa, Md. ; Pucadyil, Thomas J. ; Chattopadhyay, Amitabha (2008) Effect of sphingomyelinase treatment on ligand binding activity of human serotonin1A receptors Biochimica et Biophysica Acta (BBA) - Biomembranes, 1778 (10). pp. 2022-2025. ISSN 0005-2736

[img]
Preview
PDF - Publisher Version
291kB

Official URL: http://linkinghub.elsevier.com/retrieve/pii/S00052...

Related URL: http://dx.doi.org/10.1016/j.bbamem.2008.07.007

Abstract

The serotonin1Areceptor is an important member of the G-protein coupled receptor family, and is involved in the generation and modulation of a variety of cognitive, behavioral, and developmental functions. We have monitored the ligand binding of the human serotonin1A receptor stably expressed in CHO cells (termed CHO-5-HT1AR) following treatment with sphingomyelinase (SMase), an enzyme that specifically catalyzes the hydrolysis of sphingomyelin into ceramide and phosphorylcholine. Our results show, for the first time, that the specific ligand binding activity of the serotonin1A receptor in membranes isolated from CHO-5-HT1AR cells is increased upon sphingomyelinase treatment. Saturation binding analysis reveals increase in binding affinity of the receptor under these conditions. This is accompanied by a reduction in membrane order, as monitored by fluorescence anisotropy of the membrane probe 1-[4-(trimethylammonio)phenyl]-6-phenyl-1,3,5-hexatriene (TMA-DPH) in intact cells. These results represent the first report on the effect of sphingomyelinase treatment on the ligand binding activity of this important neurotransmitter receptor.

Item Type:Article
Source:Copyright of this article belongs to Elsevier Science.
Keywords:Serotonin1A Receptor; Sphingomyelin; Sphingomyelinase; Ligand Binding Activity; Fluorescence Anisotropy
ID Code:7231
Deposited On:25 Oct 2010 12:06
Last Modified:16 May 2016 17:28

Repository Staff Only: item control page